About
Technology
Issues
FAQ
Links
Official Page
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.